KOSDAQ · Healthcare · ₩61B
₩5,430-2.51%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.9% · as of 26.09.11
Among 34 바이오 peers
Quarterly Revenue Growth
“생산 서비스 매출은 확인됐고 신약 진척이 다음 열쇠예요.”
In the company's words · 2026 2분기 filing